SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-339158
Filing Date
2017-11-13
Accepted
2017-11-09 19:57:52
Documents
52
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d459525d10q.htm 10-Q 345360
2 EX-10.2 d459525dex102.htm EX-10.2 69141
3 EX-31.1 d459525dex311.htm EX-31.1 9086
4 EX-31.2 d459525dex312.htm EX-31.2 9246
5 EX-32.1 d459525dex321.htm EX-32.1 2820
6 EX-32.2 d459525dex322.htm EX-32.2 2913
  Complete submission text file 0001193125-17-339158.txt   2365054

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pirs-20170930.xml EX-101.INS 328022
8 XBRL TAXONOMY EXTENSION SCHEMA pirs-20170930.xsd EX-101.SCH 38010
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20170930_cal.xml EX-101.CAL 41614
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20170930_def.xml EX-101.DEF 93504
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20170930_lab.xml EX-101.LAB 267773
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20170930_pre.xml EX-101.PRE 170366
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 171192484
SIC: 8731 Services-Commercial Physical & Biological Research